Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385548
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-04-11
Brief Title:
Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients Protocol VHIO21001 - LiDer
Sponsor:
Vall dHebron Institute of Oncology
Organization:
Vall dHebron Institute of Oncology
Organization Data
Organization:
Vall dHebron Institute of Oncology
Class:
OTHER
Study ID:
VHIO21001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vall dHebron Institute of Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None